Aging may be driven not only by the gradual accumulation of cellular damage, but also by biological programs that continue running long after their useful purpose has ended, according to a new research perspective published in Aging-US. The article, titled “A Brief History of the Hyperfunction Theory of Aging and Future Directions,” examines how developmental processes linked to growth, reproduction, and tissue maintenance could become major drivers of decline later in life. Written by João Pedro de Magalhães of the University of Birmingham, the perspective argues that this “hyperfunction” framework deserves greater attention as scientists search for ways to extend healthy lifespan.
Published in Volume 18 of Aging on July 24, 2026, the article does not report new laboratory experiments. Instead, it traces the intellectual history of a theory that challenges the traditional view of aging as primarily the result of accumulated molecular damage. The conventional model emphasizes the gradual buildup of DNA mutations, oxidative stress, mitochondrial failure, damaged proteins, and other forms of cellular deterioration. The hyperfunction theory proposes that many age-related changes arise because biological systems designed to promote growth and development remain active—or become dysregulated—through adulthood.
The theory does not suggest that aging is deliberately programmed in the same way as an organism’s development. Rather, it describes aging as an unintended consequence of developmental programs that fail to shut down completely. During early life, signaling networks such as the insulin-like growth factor-1, or IGF-1, pathway and the mechanistic target of rapamycin, known as mTOR or TOR, stimulate cell growth, protein production, metabolism, and reproduction. These processes are essential in youth, but their continued activation later in life can promote inflammation, abnormal cell growth, loss of cellular balance, and declining tissue function.
The perspective follows the evolution of these ideas from nineteenth-century theories of aging to the work of Clive McCay, whose caloric-restriction experiments helped establish that lifespan could be altered by changing an organism’s nutritional environment. It also discusses George Williams’ theory of antagonistic pleiotropy, which proposed that genes beneficial early in life could produce harmful effects in old age. A gene that enhances growth or reproductive success before reproduction, for example, may be favored by natural selection even if the same activity contributes to disease decades later, when evolutionary pressure is weaker.
A central figure in the modern development of the hyperfunction theory was the late Mikhail Blagosklonny. He argued that aging could result from “quasi-programs,” biological processes that resemble programmed development but continue after their adaptive function has ended. In this model, aging is not an actively selected outcome, but a form of runaway or excessive biological activity. Persistent growth signaling could gradually shift tissues away from maintenance and repair, helping explain why aging is associated with conditions such as cancer, fibrosis, immune dysfunction, metabolic disease, and the progressive loss of regenerative capacity.
Several findings from animal research have increased interest in this framework. Single-gene interventions have extended lifespan in organisms ranging from worms to mice, demonstrating that aging is biologically modifiable rather than completely fixed. In mice, reduced growth hormone and IGF-1 signaling can delay multiple features of aging, while rapamycin, a drug that inhibits TOR signaling, has extended lifespan in several experimental settings. These interventions affect regulatory networks that control growth, metabolism, protein synthesis, and cellular recycling, suggesting that lifespan may be influenced by coordinated biological systems rather than only by the repair of isolated molecular lesions.
Caloric restriction is also presented as evidence that aging involves regulated mechanisms. Reducing calorie intake without causing malnutrition can extend lifespan in many laboratory organisms and alter insulin signaling, TOR activity, mitochondrial metabolism, inflammation, and stress resistance. Although the precise effects vary between species and experimental conditions, the intervention is difficult to explain as a simple reduction in random damage. Instead, it appears to activate a physiological state that prioritizes maintenance and survival over growth and reproduction. The author nevertheless stresses that molecular damage remains important, particularly in diseases such as cancer, and may interact continuously with programmatic mechanisms.
The perspective identifies partial cellular reprogramming as one of the most important future tests of the hyperfunction theory. Reprogramming techniques use defined factors to alter gene regulation and partially reset aspects of cellular age without fully converting mature cells into pluripotent stem cells. In principle, this approach could restore youthful patterns of gene expression, improve tissue repair, and reverse some age-associated dysfunction. However, the same pathways that increase plasticity and rejuvenation may also create risks, including uncontrolled proliferation and tumor formation. Developing tissue-specific reprogramming strategies could therefore be essential for separating beneficial rejuvenation from dangerous loss of cellular identity.
Magalhães concludes that no single theory is likely to explain every aspect of aging. Developmental programs, epigenetic changes, metabolic regulation, chronic inflammation, DNA damage, mitochondrial dysfunction, and protein quality control may all contribute, with their relative importance differing among tissues and diseases. The hyperfunction framework offers a way to connect evolutionary theory with experimental longevity research and may help identify interventions that restore biological balance rather than merely treating individual symptoms. The article argues that integrating developmental biology, genetics, epigenetics, and regenerative medicine could reveal why aging differs across species and how its most harmful processes might eventually be selectively modified.
Subject of Research: Aging biology and the hyperfunction theory of aging
Article Title: A Brief History of the Hyperfunction Theory of Aging and Future Directions
News Publication Date: August 6, 2026
Web References: https://doi.org/10.18632/aging.206403; Aging-US Volume 18
References: de Magalhães, J. P. “A Brief History of the Hyperfunction Theory of Aging and Future Directions.” Aging-US, published July 24, 2026. DOI: 10.18632/aging.206403
Keywords: aging, longevity, hyperfunction theory, programmatic aging, quasi-programs, antagonistic pleiotropy, caloric restriction, rapamycin, mTOR, IGF-1, cellular reprogramming
